天然产物研究与开发 ›› 2015, Vol. 27 ›› Issue (12): 2027-2030.doi: 10.16333/j.1001-6880.2015.12.005

• 研究论文 • 上一篇    下一篇

羟基丹参酮IIA的合成及体外抗肿瘤作用

张丽娟,徐文清*,江城峰,杨福军,沈秀   

  1. 中国医学科学院放射医学研究所 天津市放射医学与分子核医学重点实验室,天津 300192
  • 出版日期:2015-12-29 发布日期:2016-01-06

Synthesis and in vitro Anti-Tumor Effects of Hydroxytanshinone IIA

ZHANG Li-juan, XU Wen-qing*, JIANG Cheng-feng, YANG Fu-jun, SHEN Xiu   

  1. Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine,Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College,Tianjin 300192,China
  • Online:2015-12-29 Published:2016-01-06

摘要: 对丹参酮IIA进行结构修饰,合成了羟基丹参酮IIA。采用MTT法考察了羟基丹参酮IIA对人宫颈癌细胞株Hela细胞,人肝癌细胞株HepG-2细胞、人胃癌细胞株SGC-7901细胞的增殖抑制作用。结果表明:羟基丹参酮IIA对三种肿瘤细胞增殖都有很好的抑制作用,抑制作用呈剂量依赖性。羟基丹参酮IIA对SGC-7901细胞抑制作用最强,其IC50为 4.18 μM;对HeLa细胞的抑制作用次之,其IC50为 6.08 μM;对HepG-2细胞抑制作用较弱,其IC50为10.20 μM。而丹参酮IIA对SGC-7901细胞、HeLa细胞和HepG-2细胞的IC50分别是17.15 μM、27.28 μM和46.34 μM。羟基丹参酮IIA抑制肿瘤细胞增殖作用明显强于丹参酮IIA(P<0.05)。

关键词: 丹参酮IIA, 羟基丹参酮IIA, Hela细胞, HepG-2细胞, SGC-7901细胞

Abstract: Hydroxytanshinone IIA was synthesized with tanshinone IIA as lead compound.MTT assay was adopted to evaluate its inhibition effect against Hela,HepG-2 and SGC-7901 cells.Results indicated that hydroxytanshinone IIA inhibited cell proliferation in a dose-dependent manner.The half inhibitory concentrations (IC50) of hydroxytanshinone IIA against SGC-7901,HeLa and HepG-2 cells were 4.18 μM,6.08 μM and 10.20 μM,respectively.But the IC50 of tanshinone IIA against SGC-7901,HeLa and HepG-2 cells were 17.15 μM,27.28 μM and 46.34 μM,respectively.The inhibition effect of hydroxytanshinone IIA to SGC-7901 cells was powerful.Compared with tanshinone IIA,hydroxytanshinone IIA significantly increased inhibition effect (P<0.05).

Key words: tanshinone IIA, hydroxytanshinone IIA, Hela cells, HepG-2 cells, SGC-7901 cells

中图分类号: 

R962